Alterity Therapeutics Files 6-K, Incorporates into Registrations
Ticker: PRNAF · Form: 6-K · Filed: Apr 7, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, administrative, securities-offering
Related Tickers: ATYT
TL;DR
Alterity Therapeutics (ATYT) filed a 6-K, linking it to existing S-8/F-3 filings. Nothing new, just admin.
AI Summary
Alterity Therapeutics Ltd. filed a Form 6-K on April 7, 2025, to incorporate by reference into its existing Registration Statements on Form S-8 and Form F-3. The filing includes an application for quotation of securities as Exhibit 99.1. Alterity Therapeutics Limited was formerly known as PRANA BIOTECHNOLOGY LTD.
Why It Matters
This filing indicates ongoing administrative and regulatory actions by Alterity Therapeutics, potentially related to its securities offerings or compliance with existing registration statements.
Risk Assessment
Risk Level: low — The filing is primarily administrative, incorporating previous documents into existing registration statements, and does not appear to introduce new material risks.
Key Players & Entities
- Alterity Therapeutics Ltd. (company) — Registrant
- PRANA BIOTECHNOLOGY LTD (company) — Former company name
- Form S-8 (document) — Registration Statement
- Form F-3 (document) — Registration Statement
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being incorporated by reference into Alterity Therapeutics' existing Registration Statements on Form S-8 and Form F-3.
What exhibits are included with this filing?
The filing includes Exhibit 99.1, which is an application for quotation of securities.
When was Alterity Therapeutics Limited previously known by another name?
Alterity Therapeutics Limited was formerly known as PRANA BIOTECHNOLOGY LTD, with a date of name change on January 5, 2001.
Which SEC Acts are relevant to this filing?
This filing is pursuant to Rule 13a-16 or 15d-163 under the Securities Exchange Act of 1934.
Does Alterity Therapeutics file annual reports under Form 20-F or 40-F?
Alterity Therapeutics indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 7, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).